Brief: Cingulate Announces Positive Top-Line Results From Fed/Fast Study Of Lead Asset Ctx-1301 For Adhd

Cingulate

23/02/2023 23:41

Feb 23 (Reuters) - Cingulate Inc  CING.O :
    * CINGULATE ANNOUNCES POSITIVE TOP-LINE RESULTS FROM
FED/FAST
STUDY OF LEAD ASSET CTX-1301 FOR ADHD
    * CINGULATE INC - PRIMARY ENDPOINTS DEMONSTRATE CTX-1301 CAN
BE
TAKEN WITH OR WITHOUT FOOD
    * CINGULATE INC - CTX-1301 IS DESIGNED AS A TRUE, ENTIRE
ACTIVE-DAY TREATMENT FOR ADHD

Source text for Eikon:  ID:nGNX7F3k9M 
Further company coverage:  CING.O 
 ((Reuters.Briefs@thomsonreuters.com;;))